Alcon's BRYTLY Redness Reliever Eye Drops Win FDA Approval, Working in One Minute for Up to 12 Hours
GENEVA — Alcon (NYSE: ALC) announced on October 16 via Business Wire that the U.S. Food and Drug Administration has approved BRYTLY Redness Reliever Eye Drops. The product is designed to reduce eye redness and is expected to become available at major retailers and online in the coming months.
According to the company's release, BRYTLY works in one minute and delivers up to 12 hours of whiter-looking eyes. The release also said the product lasts up to 50 percent longer than Lumify, based on the cited label claims.
Alcon, headquartered in Geneva, Switzerland, and listed on the New York Stock Exchange, is a global eye-care company whose businesses span surgical equipment and vision care products. The approval adds a new redness reliever to its over-the-counter eye drop lineup.
Published by GSM · USA (original Chinese edition)
Photo: 爱尔康公司资料图（Wikimedia Commons） / Alcon company image (Wikimedia Commons)
